Global Injectable Drug Delivery Market: Trends Analysis & Forecasts to 2021

  • ID: 3802697
  • Report
  • Region: Global
  • 100 pages
  • Infinium Global Research
1 of 4

FEATURED COMPANIES

  • Alkermes PLC
  • ELI Lilly and Company
  • Gerresheimer AG
  • Pfizer, Inc.
  • Sandoz
  • Schott AG
  • MORE
The global Injectable Drug Delivery market is projected to reach USD 582.6 billion by the end of 2021, growing with a CAGR of 12.2% from 2016 to 2021. Injectable drug delivery is defined as administration of a drug or drugs directly into patient’s blood circulation through a delivery device. It is considered as the most common and effective route of administration of most therapeutic agents to achieve the desired quick response.

The injectable route of drug administration is expected to continue to be an important delivery system. This has been attributed to reasons that injectable drug delivery system allows administration of drugs with poor oral bioavailability, delivery of the drug at the site of action, targeted drug delivery system.

Reduction in the number of injection is achieved by various technologies such as controlled release, targeted delivery and needle free delivery thus overcoming the problems associated with conventional injectable drug delivery. This has also helped in improving quality of therapy. Injectable drug delivery has also proved beneficial in many cases such as unconsciousness, emergency conditions and nausea, due to rapid onset of action. The basic requirement for injectable drug delivery is that it should be pyrogen free, sterile and isotonic.

Segments Covered:

The report segments the global Injectable Drug Delivery market by type, therapeutic application, usage pattern, mode of administration, end user, and region. The types include devices and formulation. The therapeutic applications include autoimmune diseases, hormonal diseases, oncology, orphan diseases, and other therapeutic applications.

The usage patterns include curative care, immunization, and other usage patterns. Furthermore, mode of administration includes skin, organs, central nervous system, and circulatory/musculoskeletal system. The end users considered in the report include hospitals/clinics, home care settings, research laboratories, pharmaceuticals and biotechnology companies, and other end users.

Geographic Coverage and Analysis:

The report provides regional analysis covering geographies such as North America, Europe, Asia-Pacific, and Rest of the World. The global injectable drug delivery market is dominated by North America and is followed by Europe. However the North American region lags behind European injectable market in self-injection devices due to low penetration rate of pen injectors in the U.S.

The emerging Asian and Latin American countries collectively represent the fastest growing market for injectables due to the increase in incidences of cancer and diabetes in patients and also their compliance to novel technologies. Furthermore, the drug and device manufacturers are focusing on major emerging injectables market of Asia and Latin America due to less stringent regulations for acquiring approvals on devices and less competition.

Companies Profiled:

The companies covered in the report include Becton, Dickinson and Company (U.S.), Baxter International Inc. (U.S.), Gerresheimer AG (Germany), Pfizer, Inc. (U.S.), Schott AG (Germany), Sandoz (Germany), Teva Pharmaceutical Industries Ltd. (Israel), and Eli Lilly and Company (U.S.).

Report Highlights:

The report provides deep insights on demand forecasts, market trends and micro and macro indicators. In addition, this report provides insights on the factors that are driving and restraining the demand of Injectable Drug Delivery globally as well as regionally. Moreover, the Growth Matrix analysis given in the report brings an insight on the investment areas that existing or new market players can consider.

The report provides insights into the market using analytical tools such as Porter’s five forces analysis and value chain analysis of Injectable Drug Delivery. Moreover, the study highlights current market trends and provides forecast from 2016 to 2021. We also have highlighted future trends in the Injectable Drug Delivery market that will impact the demand during the forecast period.

Moreover, the competitive analysis given in each regional market brings an insight on the market share of the leading players. Additionally, the analysis highlights rise and fall in the market shares of the key players in the market. This report will help manufacturers, suppliers and distributors of the Injectable Drug Delivery market to understand the present and future trends in this market and formulate their strategies accordingly.
READ MORE
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • Alkermes PLC
  • ELI Lilly and Company
  • Gerresheimer AG
  • Pfizer, Inc.
  • Sandoz
  • Schott AG
  • MORE
1. Preface
1.1 Report Description
1.2 Research Methods
1.3 Research Approaches

2. Executive Summary

3. Global Injectable Drug Delivery Market Overview
3.1 Introduction
3.2 Market Dynamics
3.2.1 Drivers
3.2.2 Restraints
3.2.3 Opportunities
3.2.4 Challenges
3.3 Porter’s Five Forces Analysis
3.4 Author - Growth Matrix Analysis
3.5 Competitive Landscape in the Injectable Drug Delivery Market

4. Global Injectable Drug Delivery Market Analysis, by Type (USD Million) 2014-2021
4.1 Devices
4.1.1 Conventional Injection Devices
4.1.2 Self-Injection Devices
4.1.3 Other Devices
4.2 Formulations
4.2.1 Conventional Drug Delivery Formulations
4.2.2 Novel Drug Delivery Formulations
4.2.3 Long-Acting Formulations

5. Global Injectable Drug Delivery Market Analysis, by Therapeutic Application (USD Million) 2014-2021
5.1 Autoimmune Diseases
5.2 Hormonal Disorders
5.3 Oncology
5.4 Orphan Diseases
5.5 Other Therapeutic Applications

6. Global Injectable Drug Delivery Market Analysis, by Usage Patterns (USD Million) 2014-2021
6.1 Curative Care
6.2 Immunization
6.3 Other Usage Patterns

7. Global Injectable Drug Delivery Market Analysis, by Mode of Administration (USD Million) 2014-2021
7.1 Skin
7.2 Organs
7.3 Central Nervous System
7.4 Circulatory/Musculoskeletal System

8. Global Injectable Drug Delivery Market Analysis, by End-User (USD Million, KT) 2014-2021
8.1 Hospitals/Clinics
8.2 Home Care Settings
8.3 Research Laboratories
8.4 Pharmaceutical and Biotechnology Companies
8.5 Other End Users

9. Global Injectable Drug Delivery Market Analysis, by Region (USD Million, KT) 2014-2021
9.1 North America
9.1.1 North America Injectable Drug Delivery Market by Type (USD Million)
9.1.2 North America Injectable Drug Delivery Market by Therapeutic Application (USD Million)
9.1.3 North America Injectable Drug Delivery Market by Usage Pattern (USD Million)
9.1.4 North America Injectable Drug Delivery Market by Mode of Administration (USD Million)
9.1.5 North America Injectable Drug Delivery Market by End-User (USD Million)

9.2 Europe
9.2.1 Europe Injectable Drug Delivery Market by Type (USD Million)
9.2.2 Europe Injectable Drug Delivery Market by Therapeutic Application (USD Million)
9.2.3 Europe Injectable Drug Delivery Market by Usage Pattern (USD Million)
9.2.4 Europe Injectable Drug Delivery Market by Mode of Administration (USD Million)
9.2.5 Europe Injectable Drug Delivery Market by End-User (USD Million)

9.3 Asia-Pacific
9.3.1 Asia-Pacific Injectable Drug Delivery Market by Type (USD Million)
9.3.2 Asia-Pacific Injectable Drug Delivery Market by Therapeutic Application (USD Million)
9.3.3 Asia-Pacific Injectable Drug Delivery Market by Usage Pattern (USD Million)
9.3.4 Asia-Pacific Injectable Drug Delivery Market by Mode of Administration (USD Million)
9.3.5 Asia-Pacific Injectable Drug Delivery Market by End-User (USD Million)

9.4 Rest of the World (RoW)
9.1.1 RoW Injectable Drug Delivery Market by Type (USD Million)
9.1.2 RoW Injectable Drug Delivery Market by Therapeutic Application (USD Million)
9.1.3 RoW Injectable Drug Delivery Market by Usage Pattern (USD Million)
9.1.4 RoW Injectable Drug Delivery Market by Mode of Administration (USD Million)
9.1.5 RoW Injectable Drug Delivery Market by End-User (USD Million)

10. Company Profiles
10.1 Baxter International, Inc.
10.2 Becton, Dickinson and Company
10.3 Gerresheimer AG
10.4 Pfizer, Inc.
10.5 Schott AG
10.6 Alkermes PLC
10.7 ELI Lilly and Company
10.8 Sandoz
10.9 Terumo Corporation
10.10 Teva Pharmaceutical Industries Ltd.
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
- Alkermes PLC
- Baxter International, Inc.
- Becton, Dickinson and Company
- ELI Lilly and Company
- Gerresheimer AG
- Pfizer, Inc.
- Sandoz
- Schott AG
- Terumo Corporation
- Teva Pharmaceutical Industries Ltd.
Note: Product cover images may vary from those shown
5 of 4
Note: Product cover images may vary from those shown
Adroll
adroll